COLL News and Press, Collegium Pharmaceutical Inc.

2024-07-20 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-10 14:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-06-24 12:56:10 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Fundamentally, the biotechnology sphere enjoys a powerful catalyst: wealth without health means nothing. Yes, it’s important to save money and invest for the future. At the same time, in...

2024-06-16 10:23:34 ET Summary This monthly article series provides a dashboard with aggregate industry metrics in healthcare. The healthcare sector is moderately overvalued relative to 11-year averages, and healthcare providers are the least overvalued subsector. Focus on IHF...

STOUGHTON, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that the U.S. Food and Drug Administrat...

2024-06-07 12:13:54 ET More on Collegium Pharmaceutical Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss' Collegium Pharmaceutical, Inc. (COLL) Q1 2024 Earnings Call Transcript Collegium announces $35 million accelerated share repurchase program ...

2024-06-07 06:30:03 ET Jefferies analyst issues BUY recommendation for COLL on June 7, 2024 04:58AM ET. The previous analyst recommendation was Underperform. COLL was trading at $31.36 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...

2024-05-30 00:58:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that management will participate in a fi...

2024-05-13 15:23:02 ET Summary Collegium Pharmaceutical, Inc. stock fell 16% on Friday after Q1 results missed expectations and a CEO replacement was announced. Despite the negative reaction, there were some positive aspects in the results and guidance. An updated analysis aro...